Effect of KRAS mutational status on disease behavior and treatment outcome in patients with metastatic colorectal cancer: intra-tumor heterogeneity and Mutational status

Faculty	Medicine	Year:	2019
Type of Publication:	ZU Hosted	Pages:
Authors:
Journal:	Journal of Gastrointestinal Oncology AME Publishing Company	Volume:

Keywords :	Effect , KRAS mutational status , disease behavior
Abstract:	-Nowadays, the outcomes of metastatic colorectal cancer (mCRC) have considerably improved. Genetic studies evaluating KRAS mutational status are important in the personalized therapy era to understand disease heterogeneity, disease behaviors, and treatment outcomes. -A major association between KRAS mutational status and both disease behavior and treatment outcomes was found in this study. Patients with KRAS mutation show advanced disease presentation, with lower PFS and overall survival.

Author Related Publications

Foad Mohamed Mohamed Abotaleb, "تقييم ال بر 53 فى مرضى أورام الغدد الليمفاوية الفيرهوجكين العنيفة المرتجة والمقاومة للعلاج بيرتوكول دى – اتش ايه بى", لايوجد, 1900 More
Foad Mohamed Mohamed Abotaleb, "دراسات كهروفسيولوجية وهستوباثولوجية فى اعتلال الاعصاب الطرفية نتيجة عقار خلوى سام (مضاد للاورام", لايوجد, 1900 More
Rasha Mohamed Mostafa Hagag, "CD25 عالية FoxP3 لخلايا تي التنظيمية في سرطان الدم الميلودى المزمن النموذجية والغير نموذجية موجبة الفيلادلفيا و علاقتها بالاستجابة للعلاج بالايميتنيب", Journal of American Science Volume 11(5); pages 34-41 2015, 2015 More
Shereen Mostafa Saleh Elshorbagy, "- CD200 supresses the Natural Killer Cells and Decreased its Activity in acute Myeloid Leukemia Patients.", . J Leukemia 3: 190, 2015 More
Ahmed Abdelrehem Ahmed Abdulrihem, "Can Resection Of Liver Metastasis Improve Survival After Resectability Conversion Chemotherapy In Patients With Metastatic Colo-Rectal Cancer?", International Journal of Advanced Research, 2016 More